Evidence from approved GLP-1 receptor agonists provides relevant context, though it is important to note that some interactions are agent-specific rather than class-wide effects
Government can drive incentives that promote innovation in funding of research at the university level and associated research labs
Red and itchy injection sites are particularly common with compounded formulations, and some users have speculated that the B12 component, with its distinctive color, may contribute to local irritation
Patients with a history of pancreatitis, gallstones, or hypertriglyceridemia face elevated baseline risk
To overcome the barriers and to improve the adherence, oral GLP-1 RAs were needed, but oral protein-based drug absorption is limited because of degradation in the stomach due to low pH, proteolytic enzyme activity, and limited permeability across the gastrointestinal (GI) epithelium